Abstract

BackgroundWe previously reported infectious HCV clones that contain the convenient reporters, green fluorescent protein (GFP) and Renilla luciferase (Rluc), in the NS5a-coding sequence. Although these viruses were useful in monitoring viral proliferation and screening of anti-HCV drugs, the infectivity and yield of the viruses were low.Methodology/Principal FindingsIn order to obtain a highly efficient HCV cultivation system, we transfected Huh7.5.1 cells [1] with JFH 5a-GFP RNA and then cultivated cells for 20 days. We found a highly infectious HCV clone containing two cell culture-adapted mutations. Two cell culture-adapted mutations which were responsible for the increased viral infectivity were located in E2 and p7 protein coding regions. The viral titer of the variant was ∼100-fold higher than that of the parental virus. The mutation in the E2 protein increased the viability of virus at 37°C by acquiring prolonged interaction capability with a HCV receptor CD81. The wild-type and p7-mutated virus had a half-life of ∼2.5 to 3 hours at 37°C. In contrast, the half-life of viruses, which contained E2 mutation singly and combination with the p7 mutation, was 5 to 6 hours at 37°C. The mutation in the p7 protein, either singly or in combination with the E2 mutation, enhanced infectious virus production about 10–50-fold by facilitating an early step of virion production.Conclusion/SignificanceThe mutation in the E2 protein generated by the culture system increases virion viability at 37°C. The adaptive mutation in the p7 protein facilitates an earlier stage of virus production, such as virus assembly and/or morphogenesis. These reporter-containing HCV viruses harboring adaptive mutations are useful in investigations of the viral life cycle and for developing anti-viral agents against HCV.

Highlights

  • Over 180 million people worldwide are chronically infected with hepatitis C virus (HCV), and are at high risk of developing chronic liver diseases such as progressive hepatic fibrosis, liver cirrhosis and hepatocellular carcinoma [2,3]

  • Cell culture supernatants obtained 5 days after transfection with Ad 9, Ad 12 and Ad 16 RNAs were examined for infectious virus production by fluorescence microscopy and tested in a TCID50 assay

  • With the results obtained using JFH 5a-green fluorescent protein (GFP) constructs of viruses with adaptive mutations (Fig. 3D), JFH 5a-Renilla luciferase (Rluc) virus constructs containing individual mutations in E2 and p7 protein each increased infectivity by,10-fold, and the JFH-R m4 virus containing both mutations showed the highest infectivity (Fig. 4B). These results indicate that the two adaptive mutations are each responsible for a similar increase the infectivity of JFH 5a-Rluc and JFH 5a-GFP viruses

Read more

Summary

Introduction

Over 180 million people worldwide are chronically infected with hepatitis C virus (HCV), and are at high risk of developing chronic liver diseases such as progressive hepatic fibrosis, liver cirrhosis and hepatocellular carcinoma [2,3]. Interferon-alpha (IFN-a) in combination with ribavirin is the only recommended therapy [4] These treatments have a moderate response rate and are associated with significant side effects [5,6]. P7 is a 63-amino-acid polypeptide that is often incompletely cleaved from E2 It has two transmembrane domains connected by a short hydrophilic segment [11]. We previously reported infectious HCV clones that contain the convenient reporters, green fluorescent protein (GFP) and Renilla luciferase (Rluc), in the NS5a-coding sequence. These viruses were useful in monitoring viral proliferation and screening of anti-HCV drugs, the infectivity and yield of the viruses were low

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.